Literature DB >> 15907371

Risk and benefit perceptions of party drug use.

Bethany White1, Louisa Degenhardt, Courtney Breen, Raimondo Bruno, Jaclyn Newman, Phoebe Proudfoot.   

Abstract

A cross-sectional survey of 372 regular ecstasy users was conducted to examine the benefits and risks perceived to be associated with the use of party drugs. A wide range of benefits and risks were reported across six drug types with some considered drug-specific. Commonly perceived risks included physical and psychological harms that were consistent with current harm reduction messages. Harm reduction campaigns may need to acknowledge benefits of drug use to ensure health promotion messages are considered credible and acceptable to users.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15907371     DOI: 10.1016/j.addbeh.2005.04.003

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  10 in total

1.  Individual and peer factors associated with ketamine use among adolescents in Taiwan.

Authors:  Kun-Hua Lee; Yi-Chun Yeh; Pin-Chen Yang; Huang-Chi Lin; Peng-Wei Wang; Tai-Ling Liu; Cheng-Fang Yen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-06-22       Impact factor: 4.785

2.  Perceived risk of methamphetamine among Chinese methamphetamine users.

Authors:  Brian C Kelly; Tieqiao Liu; Xiaozhao Yosef Yang; Guanbai Zhang; Wei Hao; Jichuan Wang
Journal:  Int J Drug Policy       Date:  2014-05-21

3.  Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression.

Authors:  Kit Sang Leung; Arbi Ben Abdallah; Jan Copeland; Linda B Cottler
Journal:  Addict Behav       Date:  2009-10-18       Impact factor: 3.913

4.  Sit Down to Float: The Cultural Meaning of Ketamine Use in Hong Kong.

Authors:  Karen Joe-Laidler; Geoffrey Hunt
Journal:  Addict Res Theory       Date:  2008-06-01

5.  Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.

Authors:  Camille Jacinto; Micheline Duterte; Paloma Sales; Sheigla Murphy
Journal:  Int J Drug Policy       Date:  2007-10-26

6.  Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study.

Authors:  Judith C Barker; Shana L Harris; Jo E Dyer
Journal:  J Psychoactive Drugs       Date:  2007-06

7.  Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.

Authors:  Rebecca M Scott; Leanne Hides; J Sabura Allen; Richard Burke; Dan I Lubman
Journal:  Psychopharmacology (Berl)       Date:  2010-01-26       Impact factor: 4.530

8.  Comparison of Stimulant-Related Presentations to Victorian Emergency Departments Pre-pandemic and During the COVID-19 Pandemic.

Authors:  Peter T Redona; Cindy Woods; Debra Jackson; Jane Hayman; Kim Usher
Journal:  Cureus       Date:  2022-09-05

9.  Perceived harmfulness of substance use: a pilot study.

Authors:  Siddharth Sarkar; Srinivas Balachander; Debasish Basu
Journal:  Indian J Community Med       Date:  2014-01

10.  'Worth the test?' Pragmatism, pill testing and drug policy in Australia.

Authors:  Andrew Groves
Journal:  Harm Reduct J       Date:  2018-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.